Rankings
▼
Calendar
PRME Q2 2021 Earnings — Prime Medicine, Inc. Revenue & Financial Results | Market Cap Arena
PRME
Prime Medicine, Inc.
$771M
Q2 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$1M
Operating Income
-$8M
Net Income
$616,000
EPS (Diluted)
$-0.04
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$6M
Free Cash Flow
-$7M
Stock-Based Comp.
$94,000
← FY 2021
All Quarters
Q3 2021 →